Hidden Reservoirs, Emerging Threats: Herbal Medicines Fuel the Spread of Antimicrobial Resistance

In many parts of the world, people rely on plants to heal their bodies. These herbal remedies, often sold as powders or liquids in local markets, are a cornerstone of daily healthcare for millions. They are used to treat everything from fevers and stomach aches to chronic conditions like diabetes. However, the journey of a plant from a field or roadside to a bottle or bag is fraught with opportunities for contamination. If the drying, grinding, or packaging processes are not clean, the final product can become a breeding ground for bacteria. This is not merely a matter of spoilage; it is a matter of public safety. When bacteria grow in these products, they can cause infections in the people who consume them. More dangerously, these bacteria can carry resistance to medicines designed to kill them. This resistance, known as antimicrobial resistance, means that standard drugs like penicillin or tetracycline no longer work. When bacteria learn to survive these drugs, they can pass that survival skill to other bacteria, creating a silent threat that spreads through communities and makes common infections harder to treat.

A team of researchers in Lagos, Nigeria, set out to investigate whether the herbal medicines sold in their local markets were acting as hidden reservoirs for these dangerous, drug-resistant bacteria. They focused on the Alimosho Local Government Area, a bustling region divided into six smaller districts, to see what was hiding inside the bottles and bags people bought every day. The scientists collected 150 different herbal products, some in liquid form and others as powders. From these samples, they isolated and identified 520 distinct bacteria. The list of culprits was long and familiar to anyone who studies infection: common offenders like Staphylococcus, Escherichia, Salmonella, and Pseudomonas. These are the kinds of bacteria that can cause serious illness if they enter the human body, especially in people with weaker immune systems.

The researchers then tested how these bacteria reacted to a wide range of antibiotics, the medicines doctors use to fight infections. The results were stark. The bacteria showed a high level of resistance to several common drugs. More than two-thirds of the bacteria could not be killed by a combination drug containing sulfamethoxazole and trimethoprim. Resistance was also high against imipenem, a powerful antibiotic often reserved for severe infections, with 63.1% of isolates showing resistance. Augmentin, a widely used penicillin-based drug, also failed to stop a large portion of the bacteria. Erythromycin and tetracycline also failed to stop a large portion of the bacteria. In contrast, the bacteria were much more easily killed by ciprofloxacin and gentamicin, suggesting that these specific drugs might still be effective against the contaminants found in these products. The study found that liquid herbal preparations were generally more contaminated with resistant bacteria than the powdered versions. Furthermore, the level of resistance varied significantly depending on which of the six districts the product came from, with some areas showing much higher rates of resistance than others.

To understand why the bacteria were so tough, the scientists looked inside them at the genetic level. They searched for specific genes that act as blueprints for resistance, allowing the bacteria to build defenses against antibiotics. They found that a significant portion of the bacterial isolates tested carried at least one of these resistance genes. The most common gene found was sul1, which helps bacteria resist sulfonamide drugs, followed closely by tetA, which protects against tetracycline. They also found genes that confer resistance to beta-lactam antibiotics and quinolones, two major classes of modern medicine. The presence of these genes confirmed that the bacteria were not just resistant by chance; they possessed the specific biological tools to survive treatment. The study noted that the distribution of these genes was not uniform across the region. Some districts had a much higher concentration of specific resistance genes than others, pointing to local differences in how the medicines were made, stored, or how the environment around them was managed.

The researchers also examined how these bacteria behaved as a group. They found that resistance to one antibiotic often came hand-in-hand with resistance to another. For instance, bacteria that could survive erythromycin were frequently the same ones that could survive tetracycline. This pattern suggests that the bacteria have accumulated multiple defenses, likely because they have been exposed to a mix of antibiotics and other chemicals in their environment. The study highlighted that while some areas had a high burden of bacteria resistant to many drugs, other areas had a different profile, with some districts showing almost no bacteria that were resistant to all tested drugs. This geographic variation suggests that the problem is not the same everywhere and that local factors, such as sanitation practices or the source of water used in making the medicines, play a crucial role.

The study concludes that the herbal medicines sold in these markets are a significant source of drug-resistant bacteria and the genes that make them resistant. These products are not just passive containers; they are active participants in the spread of resistance. When people consume these contaminated remedies, they are not only risking infection from the bacteria themselves but are also potentially introducing these tough, resistant strains into their own bodies. Once inside, these bacteria can share their resistance genes with the natural bacteria living in the gut, creating a new, harder-to-treat threat within the community. The researchers emphasize that the current system of quality control is insufficient. They call for stricter regulations, better manufacturing practices, and regular testing to ensure that these traditional remedies remain safe. Without these changes, the very products people rely on for health could become a vector for a growing public health crisis, turning a trusted source of healing into a hidden reservoir of danger.